219 related articles for article (PubMed ID: 32120283)
21. Phase III trial evaluating the addition of paclitaxel to doxorubicin followed by cyclophosphamide, methotrexate, and fluorouracil, as adjuvant or primary systemic therapy: European Cooperative Trial in Operable Breast Cancer.
Gianni L; Baselga J; Eiermann W; Porta VG; Semiglazov V; Lluch A; Zambetti M; Sabadell D; Raab G; Cussac AL; Bozhok A; Martinez-Agulló A; Greco M; Byakhov M; Lopez JJ; Mansutti M; Valagussa P; Bonadonna G
J Clin Oncol; 2009 May; 27(15):2474-81. PubMed ID: 19332727
[TBL] [Abstract][Full Text] [Related]
22. A retrospective review of 145 patients with angiosarcoma: Radiation therapy, extent of resection and chemotherapy are important predictors of survival.
Smrke A; Hamm J; Karvat A; Simmons C; Srikanthan A
Mol Clin Oncol; 2020 Aug; 13(2):179-185. PubMed ID: 32714543
[TBL] [Abstract][Full Text] [Related]
23. Intensification of Treatment for Angiosarcoma of the Breast with Accelerated Hyperfractionated Radiation, Hyperthermia, and Surgical Resection.
Molitoris JK; Chhabra A; Snider JW; Harvilla N; Okonkwo N; Nichols EM; Vujaskovic Z; Ioffe OB; Kesmodel SB; Feigenberg SJ
Cureus; 2017 Jun; 9(6):e1406. PubMed ID: 30944783
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the use and efficacy of (neo)adjuvant chemotherapy in angiosarcoma: a multicentre study.
Constantinidou A; Sauve N; Stacchiotti S; Blay JY; Vincenzi B; Grignani G; Rutkowski P; Guida M; Hindi N; Klein A; Thibaud V; Sufliarsky J; Desar I; Steeghs N; Litiere S; Gelderblom H; Jones RL
ESMO Open; 2020 Aug; 5(4):. PubMed ID: 32847839
[TBL] [Abstract][Full Text] [Related]
25. Phase II study of neoadjuvant therapy with nab-paclitaxel and cisplatin followed by surgery in patients with locally advanced esophageal squamous cell carcinoma.
Fan Y; Jiang Y; Zhou X; Chen Q; Huang Z; Xu Y; Gong L; Yu H; Yang H; Liu J; Lei T; Zhao Q; Mao W
Oncotarget; 2016 Aug; 7(31):50624-50634. PubMed ID: 27244882
[TBL] [Abstract][Full Text] [Related]
26. Rare case of radiotherapy-induced angiosarcoma (RIAS) after conservative and radical treatment of breast cancer: About two cases and review of the literature.
Amghar A; El Abbassi I; Benchrifi Y; Mustapha B; Mohammed E; Mohammed E
Int J Surg Case Rep; 2024 Jan; 114():109050. PubMed ID: 38113566
[TBL] [Abstract][Full Text] [Related]
27. Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.
Main C; Bojke L; Griffin S; Norman G; Barbieri M; Mather L; Stark D; Palmer S; Riemsma R
Health Technol Assess; 2006 Mar; 10(9):1-132. iii-iv. PubMed ID: 16545208
[TBL] [Abstract][Full Text] [Related]
28. SWOG S0800 (NCI CDR0000636131): addition of bevacizumab to neoadjuvant nab-paclitaxel with dose-dense doxorubicin and cyclophosphamide improves pathologic complete response (pCR) rates in inflammatory or locally advanced breast cancer.
Nahleh ZA; Barlow WE; Hayes DF; Schott AF; Gralow JR; Sikov WM; Perez EA; Chennuru S; Mirshahidi HR; Corso SW; Lew DL; Pusztai L; Livingston RB; Hortobagyi GN
Breast Cancer Res Treat; 2016 Aug; 158(3):485-95. PubMed ID: 27393622
[TBL] [Abstract][Full Text] [Related]
29. A phase II study of multimodality treatment for locally advanced cervical cancer: neoadjuvant carboplatin and paclitaxel followed by radical hysterectomy and adjuvant cisplatin chemoradiation.
Dueñas-Gonzalez A; López-Graniel C; González-Enciso A; Cetina L; Rivera L; Mariscal I; Montalvo G; Gómez E; de la Garza J; Chanona G; Mohar A
Ann Oncol; 2003 Aug; 14(8):1278-84. PubMed ID: 12881393
[TBL] [Abstract][Full Text] [Related]
30. Combination of Cisplatin, Ifosfamide, and Adriamycin as Neoadjuvant Chemotherapy for Extremity Soft Tissue Sarcoma: A Report of Twenty-Eight Patients.
Wang B; Yu X; Xu S; Xu M
Medicine (Baltimore); 2016 Jan; 95(4):e2611. PubMed ID: 26825914
[TBL] [Abstract][Full Text] [Related]
31. Neoadjuvant chemotherapy-specific and overall treatment outcomes in patients with cutaneous angiosarcoma of the face with periorbital involvement.
DeMartelaere SL; Roberts D; Burgess MA; Morrison WH; Pisters PW; Sturgis EM; Ho V; Esmaeli B
Head Neck; 2008 May; 30(5):639-46. PubMed ID: 18213722
[TBL] [Abstract][Full Text] [Related]
32. Paclitaxel and pegylated-liposomal doxorubicin are both active in angiosarcoma.
Skubitz KM; Haddad PA
Cancer; 2005 Jul; 104(2):361-6. PubMed ID: 15948172
[TBL] [Abstract][Full Text] [Related]
33. Pathologic Complete Response with Neoadjuvant Doxorubicin and Cyclophosphamide Followed by Paclitaxel with Trastuzumab and Pertuzumab in Patients with HER2-Positive Early Stage Breast Cancer: A Single Center Experience.
Singh JC; Mamtani A; Barrio A; Morrow M; Sugarman S; Jones LW; Yu AF; Argolo D; Smyth LM; Modi S; Schweber S; Boafo C; Patil S; Norton L; Baselga J; Hudis CA; Dang C
Oncologist; 2017 Feb; 22(2):139-143. PubMed ID: 28167568
[TBL] [Abstract][Full Text] [Related]
34. [Treatment and prognosis of stage IV alveolar soft part sarcoma].
Zhao J; Yang Y
Zhonghua Zhong Liu Za Zhi; 2012 Dec; 34(12):932-6. PubMed ID: 23336381
[TBL] [Abstract][Full Text] [Related]
35. Neoadjuvant chemotherapy for primary cutaneous/soft tissue angiosarcoma: Determining tumor behavior prior to surgical resection.
Oxenberg J; Khushalani NI; Salerno KE; Attwood K; Kane JM
J Surg Oncol; 2015 Jun; 111(7):829-33. PubMed ID: 25772798
[TBL] [Abstract][Full Text] [Related]
36. Long-Term Survival due to Chemotherapy including Paclitaxel in a Patient with Metastatic Primary Splenic Angiosarcoma.
Takehara M; Miyamoto H; Fujino Y; Tomonari T; Taniguchi T; Kitamura S; Okamoto K; Sogabe M; Sato Y; Muguruma N; Bando Y; Takayama T
Case Rep Gastroenterol; 2021; 15(3):910-918. PubMed ID: 34720843
[TBL] [Abstract][Full Text] [Related]
37. Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-naïve patients with locally advanced or metastatic breast carcinoma.
Hsu C; Huang CS; Chao TY; Lu YS; Bu CF; Chen MM; Chang KJ; Cheng AL
Cancer; 2002 Nov; 95(10):2044-50. PubMed ID: 12412156
[TBL] [Abstract][Full Text] [Related]
38. Paclitaxel as neoadjuvant therapy for high grade angiosarcoma of the spleen: a brief report and literature review.
Vakkalanka B; Milhem M
Clin Med Insights Oncol; 2010 Oct; 4():107-10. PubMed ID: 20981134
[TBL] [Abstract][Full Text] [Related]
39. Two sequential studies for primary peritoneal carcinoma: induction with weekly cisplatin followed by either cisplatin-doxorubicin-cyclophosphamide or paclitaxel-cisplatin.
Piver MS; Eltabbakh GH; Hempling RE; Recio FO; Blumenson LE
Gynecol Oncol; 1997 Nov; 67(2):141-6. PubMed ID: 9367697
[TBL] [Abstract][Full Text] [Related]
40. Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials.
Thigpen T; Vance R; Puneky L; Khansur T
Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S97-107. PubMed ID: 7835816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
